Cargando…

Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline

BACKGROUND: Gastric cancer is one of the most common malignancies worldwide. Epirubicin (EPI) is used extensively in the treatment of multiple cancers despite its tendency to induce multidrug resistance though overexpression of the ABCB1 efflux pump. However, this overexpression can be disrupted usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felipe, Aledson Vitor, de Oliveira, Juliana, Moraes, Andrea Aparecida, de França, Jerônimo Pereira, da Silva, Tiago Donizetti, Forones, Nora Manoukian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031827/ https://www.ncbi.nlm.nih.gov/pubmed/29801407 http://dx.doi.org/10.22034/APJCP.2018.19.5.1237

Ejemplares similares

DNA methylation as an epigenetic biomarker in colorectal cancer
por: SILVA, TIAGO DONIZETTI, et al.
Publicado: (2013)

Study of the polymorphisms of cyclooxygenase-2 (−765G>C) and 5-lipoxygenase (1708G>A) in patients with colorectal cancer
por: PIMENTA, CÉLIA APARECIDA MARQUES, et al.
Publicado: (2014)

Fecal Genetic Mutations and Human DNA in Colorectal Cancer and Polyps Patients
por: Lima, Jacqueline, et al.
Publicado: (2019)

An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
por: Doyle, L. A., et al.
Publicado: (1995)

Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages
por: Junior, Adiel Goes de Figueiredo, et al.
Publicado: (2018)

Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines.
por: O'Neill, G. M., et al.
Publicado: (1998)

Heparan Sulfate Proteoglycans in Human Colorectal Cancer
por: Vicente, Carolina Meloni, et al.
Publicado: (2018)

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
por: Scheithauer, W., et al.
Publicado: (1993)

Development of Mouse Ascites Tumour Sublines Resistant to Triethylene Melamine
por: Williams, Anna Maria, et al.
Publicado: (1961)

Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells
por: Lin, Guan-Liang, et al.
Publicado: (2017)

Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer
por: Cavagnari, Mariana Abe Vicente, et al.
Publicado: (2019)

The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines
por: Kostrzewa-Nowak, D, et al.
Publicado: (2005)

Reversal of multidrug resistance by surfactants.
por: Woodcock, D. M., et al.
Publicado: (1992)

Weekly epirubicin in patients with hormone-resistant prostate cancer
por: Petrioli, R, et al.
Publicado: (2002)

Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
por: Stephens, T. C., et al.
Publicado: (1986)

Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines
por: Chen, Ming, et al.
Publicado: (2015)

Draft Genome Sequence of the Multiple Antibiotic Resistant Pseudomonas aeruginosa PAO1-UB Subline
por: Chua, Kah-Ooi, et al.
Publicado: (2022)

Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer
por: Seneme, Elisa Frederico, et al.
Publicado: (2022)

Reversing multidrug resistance by tyrosine kinase inhibitors
por: He, Miao, et al.
Publicado: (2012)

Synthesis of Altissimacoumarin D and Other Prenylated Coumarins and Their Ability to Reverse the Multidrug Resistance Phenotype in Candida albicans
por: Silva, Anna Claudia, et al.
Publicado: (2023)

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies
por: Afonso de Lima, Carolina, et al.
Publicado: (2020)

Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines
por: ARAKAWA, YASUHIRO, et al.
Publicado: (2013)

Genomic Adaption and Mutational Patterns in a HaCaT Subline Resistant to Alkylating Agents and Ionizing Radiation
por: Ullmann, Reinhard, et al.
Publicado: (2021)

Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline
por: Boichuk, Sergei, et al.
Publicado: (2023)

Intracellular Levels of Two Cyclosporin Derivatives Valspodar (PSC 833) and Cyclosporin A Closely Associated with Multidrug Resistance‐modulating Activity in Sublines of Human Colorectal Adenocarcinoma HCT‐15
por: Uchiyama‐Kokubu, Noriko, et al.
Publicado: (2001)

Transactions on rough sets IV: journal subline
por: Hutchison, David, et al.
Publicado: (2005)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells
por: Xu, Jiali, et al.
Publicado: (2023)

Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line
por: Xie, Si Ming, et al.
Publicado: (2010)

Synthesis of 5-oxyquinoline derivatives for reversal of multidrug resistance
por: Dittrich, Torsten, et al.
Publicado: (2012)

Nanodrug delivery in reversing multidrug resistance in cancer cells
por: Kapse-Mistry, Sonali, et al.
Publicado: (2014)

Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
por: Ye, Qingmei, et al.
Publicado: (2019)

Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance
por: Deng, Zhuo-fen, et al.
Publicado: (2022)

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
por: Capolongo, L., et al.
Publicado: (1993)

Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
por: Souissi, Wided, et al.
Publicado: (2022)

Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2–3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
por: Juang, Vivian, et al.
Publicado: (2016)

Heterogeneity in Arterial Remodeling among Sublines of Spontaneously Hypertensive Rats
por: Bakker, Erik N. T. P., et al.
Publicado: (2014)

Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy
por: Song, Bin, et al.
Publicado: (2015)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
por: de VerdiÃ¨re, A. C., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_mqrfaqkl7v0eqti92b66r9ral9